Liu JS - Search Results

1

Frankel AE, Carter C, Kuo SR, Woo JH, Mauldin J, Liu JS. Frankel AE, et al. Among authors: liu js. Anticancer Agents Med Chem. 2011 Dec;11(10):983-92. doi: 10.2174/187152011797927643. Anticancer Agents Med Chem. 2011. PMID: 22023048

2

Antibody internalization after cell surface antigen binding is critical for immunotoxin development.

Kuo SR, Alfano RW, Frankel AE, Liu JS. Kuo SR, et al. Among authors: liu js. Bioconjug Chem. 2009 Oct 21;20(10):1975-82. doi: 10.1021/bc900333j. Epub 2009 Sep 28. Bioconjug Chem. 2009. PMID: 19785403

3

Anti-caveolin-1 antibodies as anti-prostate cancer therapeutics.

Kuo SR, Tahir SA, Park S, Thompson TC, Coffield S, Frankel AE, Liu JS. Kuo SR, et al. Among authors: liu js. Hybridoma (Larchmt). 2012 Apr;31(2):77-86. doi: 10.1089/hyb.2011.0100. Hybridoma (Larchmt). 2012. PMID: 22509911 Free PMC article.

4

Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells.

Kuo SR, Wong L, Liu JS. Kuo SR, et al. Among authors: liu js. Protein Eng Des Sel. 2012 Oct;25(10):561-9. doi: 10.1093/protein/gzs040. Epub 2012 Jun 27. Protein Eng Des Sel. 2012. PMID: 22740616

5

Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1).

Woo JH, Bour SH, Dang T, Lee YJ, Park SK, Andreas E, Kang SH, Liu JS, Neville DM Jr, Frankel AE. Woo JH, et al. Among authors: liu js. Cancer Immunol Immunother. 2008 Aug;57(8):1225-39. doi: 10.1007/s00262-008-0457-x. Epub 2008 Feb 7. Cancer Immunol Immunother. 2008. PMID: 18256829 Free PMC article.

6

Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia.

Frankel A, Liu JS, Rizzieri D, Hogge D. Frankel A, et al. Among authors: liu js. Leuk Lymphoma. 2008 Mar;49(3):543-53. doi: 10.1080/10428190701799035. Leuk Lymphoma. 2008. PMID: 18297533 Clinical Trial.

7

Phosphorylation of replication protein A by S-phase checkpoint kinases.

Liu JS, Kuo SR, Melendy T. Liu JS, et al. DNA Repair (Amst). 2006 Mar 7;5(3):369-80. doi: 10.1016/j.dnarep.2005.11.007. Epub 2006 Jan 18. DNA Repair (Amst). 2006. PMID: 16412704

8

GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.

Woo JH, Liu JS, Kang SH, Singh R, Park SK, Su Y, Ortiz J, Neville DM Jr, Willingham MC, Frankel AE. Woo JH, et al. Among authors: liu js. Protein Expr Purif. 2008 Mar;58(1):1-11. doi: 10.1016/j.pep.2007.11.006. Epub 2007 Nov 22. Protein Expr Purif. 2008. PMID: 18160309

9

Comparison of checkpoint responses triggered by DNA polymerase inhibition versus DNA damaging agents.

Liu JS, Kuo SR, Melendy T. Liu JS, et al. Mutat Res. 2003 Nov 27;532(1-2):215-26. doi: 10.1016/j.mrfmmm.2003.08.018. Mutat Res. 2003. PMID: 14643438

10

DNA damage-induced RPA focalization is independent of gamma-H2AX and RPA hyper-phosphorylation.

Liu JS, Kuo SR, Melendy T. Liu JS, et al. J Cell Biochem. 2006 Dec 1;99(5):1452-62. doi: 10.1002/jcb.21066. J Cell Biochem. 2006. PMID: 16927366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,301 results

Search Page

Filters